Connexin 36/GJD2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-10395
Key Product Details
Species Reactivity
Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of Rat Connexin 36/GJD2 (NP_062154). Peptide sequence GGGGSGGSKREDKKLQNAIVNGVLQNTETTSKETEPDCLEVKELAPHPSG
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
35 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for Connexin 36/GJD2 Antibody
Western Blot: Connexin 36/GJD2 Antibody [NBP3-10395]
Western Blot: Connexin 36/GJD2 Antibody [NBP3-10395] - Western blot analysis of Connexin 36/GJD2 in Rat Kidney lysates. Antibody dilution at 1.0ug/mlApplications for Connexin 36/GJD2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Connexin 36/GJD2
Alternate Names
CX36, GJD2
Gene Symbol
GJD2
Additional Connexin 36/GJD2 Products
Product Specific Notices for Connexin 36/GJD2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...